Teva CEO: Tough year ahead, but we're hitting cost-cutting targets - Israel News - The Jerusalem Post
Teva CEO on decimated share price: "It's rational enough from a market point of view"
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Ambassador views Teva CEO as important player in potential vaccine alliance
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
In letter to Israeli PM, Teva CEO apologizes for drug-maker's sorry state | The Times of Israel
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
Teva CEO Erez Vigodman Resigns
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down
Teva CEO Erez Vigodman Steps Down | CHEManager
Teva chooses new CEO
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Teva CEO Vigodman steps down
Teva CEO reportedly wanted to stay in his job | The Times of Israel
Teva's new CEO shakes up management, to combine divisions | Reuters
US Congress grills Teva CEO on Copaxone price hikes - Globes
Teva CEO Erez Vigodman to Step Down - WSJ
